Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials

UCLA's Jonsson Comprehensive Cancer Center

UCLA's Jonsson Comprehensive Cancer Center
In the News
Features
Videos
Events Videos
Patient and Survivor Videos
Informational Videos
News Clips
Audio/Podcasts
Researcher Profiles
Patient and Survivor Stories
UCLA Cancer Discoveries
Foundation News
eNews Sign Up
News Media Guidelines
JCCC Expert List
Media Relations Contact
 
Take the Jonsson Cancer Center Site Survey

Dr. Antoni Ribas Talks Secondary Skin Cancers with BRAF Inhibitor Zelboraf and How They Can Be Prevented

POSTED: Feb. 7, 2012 Share

In this 10-minute video interview, watch UCLA Jonsson Comprehensive Cancer Center researcher Dr. Antoni Ribas discuss recent findings that can be used to develop new treatments for advanced squamous cell carcinoma. He also explains how MEK inhibitor drugs in clinical trials can now also be used to treat the disease. (From CurrentMedicine.tv)
Last updated: 7/27/2012 1:32:53 PM